ORIENTTECH’s topline growth hinges on annuity mix execution (NOC/SOC, government contracts) and hardware recovery timing; bottom-line leverage requires margin normalization post-FY26 contract resets, with AI tailwinds as upside optionalities.
📊 Base Case (50% Probability)
Key Variables: Supply chain normalizes by late FY27; NOC/SOC hits 70% utilization by FY28.
Outcome: Revenue grows 12–15% CAGR to ₹850–900 crore FY27, with EBITDA margins recovering to 7–9% on services mix improvement. EPS ₹2.50–3.00 as government/pharma contracts scale.
MUTHOOTFIN: Gold loan structural tailwinds and regulatory support underpin 18–22% AUM growth, but earnings quality hinges on NPA recovery sustainability and opex discipline; margins face 50–100 bps compression if cost inflation outpaces revenue, while competitive and macro risks cap upside to low-teens EPS growth.
📊 Base Case (50% Probability)
Key Variables: Gold prices stable (±5%), MCLR pass-through in H2, regulated branch growth.
Outcome: AUM grows 18–22%, NIM stable at ~7.5% (recoveries offset funding lag). Opex growth moderates to 15%, margins 26–28%. EPS grows 8–12%, driven by gold loan dominance and subsidiary turnarounds. Guidance clarity supports valuation rerating.
ZYDUSLIFE’s topline: 12–15% CAGR driven by US specialty, India chronic portfolio, and International Markets; Bottomline: 8–10% EPS growth contingent on margin stability and R&D efficiency; Margins: 23–25% EBITDA range, with upside from biosimilar scaling and downside from acquisition dilution.
📊 Base Case (50% Probability)
DIVISLAB’s growth relies on CS (57% mix), with generics resilient but pressured by pricing. Bottomline depends on CS commercialization (CY27) and cost pass-through, while margins face labor/raw material volatility, partly offset by backward integration and automation over 2–3 years.
📊 Base Case (50% Probability)
Key Variables: (1) 2/3 CS projects commercialize in Q3–Q4 CY27; (2) Generic pricing stabilizes (China’s rebate removal lifts API prices by 3–5%). Outcome: Revenue 8–10% CAGR, EBITDA margins expand 50 bps (CS mix shift), and gross asset turnover improves to 1.4x by FY28. EPS grows 8–12% annually.
Continue reading “DIVISLAB – Q3 FY26 Earnings Call – 11-Feb-26”Passenger rail to drive 70%+ growth (18–25% CAGR), while freight lags; high-speed rail and MRVC remain wildcards. TITAGARH’s EBITDA margins could reach 13–15% by FY’28 with backward integration, but freight volatility and execution risks loom. Passenger scale and aluminium integration are margin-critical; freight stable yet input-sensitive.
📊 Base Case (50% Probability)
MAZDOCK’s topline: Structural defense tailwinds and order book visibility support 8–12% revenue CAGR, but execution risks cap upside; bottomline: EBITDA margins likely range-bound at 16–18% barring supply chain shocks; dividends: Sustainable at current payout ratios but vulnerable to capex trade-offs for next-gen projects.
📊 Base Case (50% Probability)
Key Variables: (1) P17A/MPV deliveries on schedule; (2) MOD budget grows at 8–10% annually.
Outcome: Revenue CAGR of 8–10%, margins stable at 16–18%. Dividend growth tracks earnings (₹8–10/share annually). FX neutrality assumed.
INDHOTEL: Findings imply sustained double-digit topline growth (12%–14%) with EBITDA margins at 39%–40% and PAT expansion (15%–18%), contingent on RevPAR resilience, acquisition execution, and capex discipline—structural diversification and asset-light scaling remain key differentiators.
📊 Base Case (50% Probability)
BBOX’s FY26 growth slows to 8–10% on execution risks, with FY27 rebound tied to supply chain recovery and $300–350M orders. Margins hold at 9–10% EBITDA, with upside to 10%+ hinging on annuity mix shift, inorganic accretion, and charge abatement.
📊 Base Case (50% Probability)
Supply chain normalizes by H2 FY27, enabling $800M backlog conversion at 80% rate. 2S delivers INR45 crore EBITDA; enterprise revenue grows 12–15%. Outcome: FY27 revenue INR7,200 crore (13% YoY); EBITDA margins expand to 9.5%. Trigger: Stable hyperscaler demand and successful Brazil cross-selling.
Continue reading “BBOX – Q3 FY26 Earnings Call – 12-Feb-26”FINCABLES’ topline growth hinges on solar/fiber structural demand and government program execution, while margins face cyclical copper risks and structural competition—expect 11–12% EBIT as the new normal. Bottomline resilience depends on cash flow discipline and auto/solar capacity utilization.
📊 Base Case (50% Probability)
Key Variables: Copper stabilizes at 13,500 INR, fiber demand sustains, gradual Birla ramp-up.
AMBER’s topline resilience (13–15% Consumer Durables, 79% Electronics growth) and margin expansion (Electronics double-digit FY27) hinge on execution of INR 6,800 Cr capex pipeline and commodity pass-through, with structural risks skewed to integration delays and cyclical RAC demand.
📊 Base Case (50% Probability)